Ternette, N., et al. Immunopeptidomic Profiling of HLA‐A2‐Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens. Proteomics. e1700465. 28/5/2018.
Ternette, N., et al. Immunopeptidomic Profiling of HLA‐A2‐Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens. Proteomics. e1700465. 28/5/2018.
Leave a Reply
You must be logged in to post a comment.